gadolinium has been researched along with Degenerative Diseases, Central Nervous System in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barkhof, F; Brouwer, I; Bø, L; Kerklingh, E; Lie, IA; Myhr, KM; Torkildsen, Ø; van Nederpelt, DR; Vrenken, H; Wesnes, K | 1 |
| Barnett, MH; Graham, SL; Klistorner, A; Klistorner, S; Parratt, J; Yiannikas, C | 1 |
| Anzai, Y; Choi, SH; Lee, H | 1 |
| Dai, X; Li, W; Luo, K; Zeng, Y; Zhang, H; Zhang, Q | 1 |
2 review(s) available for gadolinium and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Glymphatic MRI techniques in sleep and neurodegenerative diseases.
Topics: Animals; Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Neurodegenerative Diseases; Sleep | 2022 |
Recent advances in development of nanomedicines for multiple sclerosis diagnosis.
Topics: Contrast Media; Ferric Compounds; Gadolinium; Humans; Magnetic Resonance Imaging; Metal Nanoparticles; Multiple Sclerosis; Myelin Sheath; Nanomedicine; Neurodegenerative Diseases; Neurology; Precision Medicine; Silicon Dioxide | 2021 |
2 other study(ies) available for gadolinium and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
Topics: Atrophy; Brain; Central Nervous System Diseases; Contrast Media; Gadolinium; Gray Matter; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neurodegenerative Diseases; Prospective Studies; Reproducibility of Results | 2022 |
Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy.
Topics: Atrophy; Central Nervous System Diseases; Choroid Plexus; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neurodegenerative Diseases | 2022 |